Filing Details
- Accession Number:
- 0001179110-17-003856
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-03-03 17:54:24
- Reporting Period:
- 2017-03-01
- Filing Date:
- 2017-03-03
- Accepted Time:
- 2017-03-03 17:54:24
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1412270 | Care.com Inc | CRCM | Services-Personal Services (7200) | 205785879 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1596938 | David Krupinski | C/O Care.com, Inc. 77 Fourth Avenue, 5Th Floor Waltham MA 02451 | Chief Technology Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 Par Value | Acquisiton | 2017-03-01 | 4,000 | $6.02 | 182,635 | No | 4 | M | Direct | |
| Common Stock, $0.001 Par Value | Disposition | 2017-03-01 | 4,000 | $10.20 | 178,635 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2017-03-01 | 4,000 | $0.00 | 4,000 | $6.02 |
| Common Stock | Restricted Stock Units | Acquisiton | 2017-03-01 | 8,706 | $0.00 | 8,706 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 72,000 | 2023-03-01 | No | 4 | M | Direct | |
| 8,706 | No | 4 | A | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on August 12, 2016.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.18 to $10.26, inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4.
- The underlying shares subject to the option vest and become exercisable in successive, equal quarterly installments over four years measured from February 1, 2013, subject to the Reporting Persons continued service relationship with the Issuer on each such vesting date.
- Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
- The restricted stock units will vest as to 25% of the original grant on March 9, 2017. The balance of the grant will vest in twelve equal quarterly installments beginning on June 9, 2017. The restricted stock units have no expiration date.
- On March 11, 2016, the Reporting Person was granted an award of restricted stock units, which vest based upon the Issuer's satisfaction of certain performance goals. On March 1, 2017, the Audit Committee of the Issuer's Board of Directors determined that certain of the performance goals had been met, resulting in the vesting of these restricted stock units.
Billionaire Hedge Funds
